Literature DB >> 20118156

Predictive factors and impact of no reflow after primary percutaneous coronary intervention in patients with acute myocardial infarction.

Gjin Ndrepepa1, Klaus Tiroch, Dritan Keta, Massimiliano Fusaro, Melchior Seyfarth, Jürgen Pache, Julinda Mehilli, Albert Schömig, Adnan Kastrati.   

Abstract

BACKGROUND: The investigation of no-reflow phenomenon after percutaneous coronary intervention (PCI) in patients with acute ST-segment-elevation myocardial infarction has therapeutic implications. We investigated the predictive factors, persistence in time, and impact of no reflow on myocardial salvage, ventricular function, and mortality. METHODS AND
RESULTS: The study included 1140 patients with ST-segment-elevation myocardial infarction undergoing primary PCI and paired scintigraphic examinations (before intervention and 7 to 14 days thereafter). After primary PCI, 108 patients had no reflow and 1032 patients had normal coronary flow. The median salvage index was 0.34 (interquartile range, 0.15, 0.49) in patients with no reflow versus 0.55 (interquartile range, 0.29, 0.81) in patients with normal flow (P<0.001). Left ventricular ejection fraction at 6 months after PCI was 47.7+/-13.1% in the no-reflow group versus 54.2+/-13.9% in the group with normal flow after PCI (P<0.001). In 80.3% of patients with no reflow, normalization of blood flow >6 months after PCI occurred and correlated with improvement in the left ventricular ejection fraction. Independent predictors of no reflow were residual flow in the infarct-related artery (P<0.001), initial perfusion defect (P=0.03), C-reactive protein (P<0.001), and previous myocardial infarction (P=0.013). Kaplan-Meier estimates of 1-year mortality were 16.7% (n=18) in patients with no reflow versus 5.5% (n=56) in patients with normal flow (hazard ratio, 3.35; 95% CI, 1.97 to 5.69; P<0.001).
CONCLUSIONS: No reflow after primary PCI was associated with reduced myocardial salvage, larger infarct size, worse left ventricular ejection fraction at 6 months, and increased risk of 1-year mortality. In 4 of 5 patients with no reflow after PCI, restoration of normal flow occurred 6 months after reperfusion.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20118156     DOI: 10.1161/CIRCINTERVENTIONS.109.896225

Source DB:  PubMed          Journal:  Circ Cardiovasc Interv        ISSN: 1941-7640            Impact factor:   6.546


  43 in total

1.  The role of von Willebrand factor and ADAMTS13 in the no-reflow phenomenon: after primary percutaneous coronary intervention.

Authors:  Bilian Zhao; Jian Li; Xinping Luo; Qing Zhou; Hua Chen; Haiming Shi
Journal:  Tex Heart Inst J       Date:  2011

2.  Double jeopardy in acute ST-segment elevation myocardial infarction.

Authors:  Rajiv Ananthakrishna; Li-Jun Wang; Liang Ping Zhao; Huay Cheem Tan
Journal:  Singapore Med J       Date:  2017-04       Impact factor: 1.858

3.  Advances in Coronary No-Reflow Phenomenon-a Contemporary Review.

Authors:  Ahmadreza Karimianpour; Anbukarasi Maran
Journal:  Curr Atheroscler Rep       Date:  2018-07-05       Impact factor: 5.113

4.  Evaluation of Short- and Long-Term Efficacy of Combined Intracoronary Administration of High-Dose Adenosine and Tirofiban during Primary Percutaneous Coronary Intervention.

Authors:  Yanbing Li; Qiang Li; Feiou Li; Min Zong; Guobin Miao; Xinchun Yang; Zichuan Tong; Jianjun Zhang
Journal:  Acta Cardiol Sin       Date:  2016-11       Impact factor: 2.672

5.  Is the difference in outcome between men and women treated by primary percutaneous coronary intervention age dependent? Gender difference in STEMI stratified on age.

Authors:  Amber M Otten; Angela H E M Maas; Jan Paul Ottervanger; Anita Kloosterman; Arnoud W J van 't Hof; Jan Henk E Dambrink; A T Marcel Gosselink; Jan C A Hoorntje; Harry Suryapranata; Menko Jan de Boer
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2013-01-31

6.  Microvascular obstruction extent predicts major adverse cardiovascular events in patients with acute myocardial infarction and preserved ejection fraction.

Authors:  Nicola Galea; Gian Marco Dacquino; Rosa Maria Ammendola; Simona Coco; Luciano Agati; Laura De Luca; Iacopo Carbone; Francesco Fedele; Carlo Catalano; Marco Francone
Journal:  Eur Radiol       Date:  2018-12-14       Impact factor: 5.315

Review 7.  ESC Working Group on Coronary Pathophysiology and Microcirculation position paper on 'coronary microvascular dysfunction in cardiovascular disease'.

Authors:  Teresa Padro; Olivia Manfrini; Raffaele Bugiardini; John Canty; Edina Cenko; Giuseppe De Luca; Dirk J Duncker; Etto C Eringa; Akos Koller; Dimitris Tousoulis; Danijela Trifunovic; Marija Vavlukis; Cor de Wit; Lina Badimon
Journal:  Cardiovasc Res       Date:  2020-03-01       Impact factor: 10.787

8.  The relationship of coronary flow to neutrophil/lymphocyte ratio in patients undergoing primary percutaneous coronary intervention.

Authors:  Korhan Soylu; Serkan Yuksel; Okan Gulel; Ali Riza Erbay; Murat Meric; Halit Zengin; Muhtar Museyibov; Erdogan Yasar; Sabri Demircan
Journal:  J Thorac Dis       Date:  2013-06       Impact factor: 2.895

9.  Left circumflex coronary artery is protected against no-reflow phenomenon following percutaneous coronary intervention for coronary artery disease.

Authors:  Toshiyuki Nagai; Takuro Hirano; Mayumi Tsunoda; Haruhiko Hosaka; Yoshikazu Kishino; Takaharu Katayama; Keisuke Matsumura; Takashi Miyagawa; Shun Kohsaka; Toshihisa Anzai; Keiichi Fukuda; Masahiro Suzuki
Journal:  Heart Vessels       Date:  2012-09-12       Impact factor: 2.037

10.  Effects of streptokinase on reflow in rescue percutaneous coronary intervention.

Authors:  Masoud Sanatkar; Hassan Shemirani; Hamid Sanei; Masoud Pourmoghaddas; Katayoun Rabiei
Journal:  ARYA Atheroscler       Date:  2013-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.